Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Animal Ethics is an Australian biotechnology company dedicated to improving animal welfare through the development of innovative pain management products for livestock. The company's core technology, Tri-Solfen, is a topical anesthetic and antiseptic gel that provides immediate and prolonged pain relief for routine husbandry procedures such as castration and dehorning. By integrating anesthesia, vasoconstriction, and antisepsis into a single application, the company addresses significant ethical and productivity concerns in the global agricultural industry. Animal Ethics works closely with international partners like Dechra Pharmaceuticals to commercialize its solutions across multiple species and geographic regions. Their products are currently approved for use in sheep, cattle, and pigs, with ongoing research into equine and companion animal applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Animal Ethics.